The Alliance for Regenerative Medicines (ARM), in its annual review of advances in the fields of cellular and genetic therapies (CGTs), as well as tissue engineering, recorded a “great year” in 2019, and there is no question that the technology […]
Read More
The Covid-19 crisis continues to be fast-moving and evolving; many statements or actions taken on one day are superseded by other developments on the next. One (small) consolation is that the experience of China, both the origin of the crisis […]
Read MoreCareMetx was founded in 2011 by two longtime industry executives, Bob Dresing and Mark Hansan, who started in the patient support field in the 1980s. Dresing is now chairman; Hansan is CEO. In 2018, it acquired VirMedica, a leading e-services […]
Read MoreA just-released study sponsored by the Pharmaceutical Care Management Assn., the trade association of PBMs, seeks to downplay PBM influence on the fate of retail pharmacy, particularly independent pharmacies. And while the study topic is another in the long-running disputes […]
Read MoreReal-world evidence—a subject of interest for years among clinical researchers—is getting closer to what might be called “real-world applications”—that is, in the decisions made routinely by physicians and by payers to prescribe drugs to patients. For the most part, RWE […]
Read More
In an innovative arrangement between a drug developer and a pharma services firm, Evoke Pharma has agreed to hand off launch, sales and distribution of what it expects to be an FDA-approved drug later this year. The handoff goes to […]
Read MoreLast fall, there were announcements of a tentative deal involving the Big 3 wholesalers and a few pharma companies, on the one side, and attorneys general for many states (representing both their states and counties and cities within them); now, […]
Read More
After a search, the board of directors at the Healthcare Distribution Alliance has chosen Chester “Chip” Davis to be president and CEO. John Gray, HDA CEO since 2004, announced his retirement last year; Davis will take over next month. Davis […]
Read MoreOwens & Minor, which operates globally as a health products distributor, is scaling down its global operations by agreeing to sell Movianto for an undisclosed price. O&M had acquired the business in 2012—and had made significant investments in Europe since […]
Read More
Civica Rx, the hospital-led nonprofit that aims to produce generic products in short supply in the US, continues to advance its innovative initiative. Most recently, it announced a seven-year collaboration with Thermo Fisher Scientific, to develop and manufacture drugs for […]
Read More
